Stocks and Investing
Stocks and Investing
Thu, February 1, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 31, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (ZBH) at Buy with Increased Target to $146 on, Jan 31st, 2018
Richard Newitter of Leerink Swann, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $142 to $146 on, Jan 31st, 2018.
Richard has made no other calls on ZBH in the last 4 months.
There are 5 other peers that have a rating on ZBH. Out of the 5 peers that are also analyzing ZBH, 2 agree with Richard's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Isaac Ro of "Goldman Sachs" Upgraded from Strong Sell to Hold on, Wednesday, December 20th, 2017
- Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold on, Thursday, November 2nd, 2017
These are the ratings of the 3 analyists that currently disagree with Richard
- Kristen Stewart of "Deutsche Bank" Upgraded from Hold to Strong Buy on, Tuesday, November 14th, 2017
- Joanne Wuensch of "BMO Capital" Maintained at Buy with Decreased Target to $135 on, Thursday, November 2nd, 2017
- David Lewis of "Morgan Stanley" Maintained at Buy with Decreased Target to $136 on, Thursday, November 2nd, 2017